Edwards Lifesciences Corp (NASDAQ: EW) Market Updates – Analysis and Comparisons

Edwards Lifesciences Corp day trading at USD 70.97 per share, then rallying to 71.1 and closing at USD 70.24 per share. A net loss of -1.28% for the day. Long term pricing analysis shows the stock trading at 13.87% lower than it’s 52week high and -35.25% higher than the 52week low. The share volume traded for the day was 3,800K which was 0 times the 50 Day Average Volume.

Edwards Lifesciences Corp had a market cap of 134,017,919K as of 19th June 2020. The Earnings Per Share (EPS) for Q4 2019 is $1.74.

Edwards Lifesciences Corp is an American medical technology company headquartered in Irvine, CA, specializing in artificial heart valves and hemodynamic monitoring.

Financial Results

Edwards Lifesciences Corp Reports First Quarter Of Fiscal 2020.

  • Sales for the quarter ended March 31, 2020, were $1.1 billion, up 14% over the prior year on both a reported and underlying basis.
  • Diluted earnings per share for the quarter were $1.47, while adjusted earnings per share grew 14%, to $1.51.
  • For the quarter, the company’s adjusted gross margin was 76.7%, consistent with the prior-year quarter.
  • Selling, general and administrative expenses increased 10% to $308 million for the quarter, driven by additions that Edwards has made in field clinical personnel to support TAVR cases in the U.S. and TMTT in Europe.
  • Free cash flow for the first quarter was $125 million, defined as cash flow from operating activities of $207 million, less capital spending of $82 million.
  • Cash, cash equivalents, and short-term investments totaled $1.0 billion at March 31, 2020. Total debt was $595 million.
  • The company purchased 3 million shares for $615 million during the first quarter.

Edwards Lifesciences Corp (19th June 2020): The Institutional Ownership as of today stood at 83.24% and the Total Value of Holdings (millions) is $ 36,229.

New Institutional Holders and other activity – As of today, the total number of shares held is 515,783,598 by 1,189 institutional holders.

LATEST NEWS:

19-June-2020:- Edwards Lifesciences Corp (NYSE: EW) CEO Sells $4,680,594.00 in Stock

Edwards Lifesciences Corp (NYSE: EW) CEO Michael A. Mussallem sold 68,550 shares of Edwards Lifesciences stock in a transaction on Monday, June 15th. The stock was sold at an average price of $68.28, for a total value of $4,680,594.00. Shares of Edwards Lifesciences stock opened at $69.98 on Friday.

13 -June-2020:- Edwards Lifesciences (NYSE: EW) Trading Down 7.1% Following Insider Selling

Shares of Edwards Lifesciences Corp (NYSE: EW) traded down 7.1% during trading on Thursday following insider selling activity. The stock traded as low as $67.90 and last traded at $68.06, 4,172,551 shares traded hands during trading. A decline of 8% from the average session volume of 4,549,575 shares. The stock had previously closed at $73.28.

13-June-2020:- Catherine M. Szyman Sells 2,249 Shares of Edwards Lifesciences Corp (NYSE: EW) Stock

Edwards Lifesciences Corp (NYSE: EW) VP Catherine M. Szyman sold 2,249 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $68.06, for a total transaction of $153,066.94. Following the completion of the sale, the vice president now directly owns 34,564 shares in the company, valued at approximately $2,352,425.84.

Leave a Reply

Your email address will not be published. Required fields are marked *